Primary |
Insomnia |
29.8% |
Product Used For Unknown Indication |
26.0% |
Drug Use For Unknown Indication |
20.0% |
Sleep Disorder |
5.8% |
Depression |
3.9% |
Hypertension |
2.1% |
Suicide Attempt |
2.0% |
Anxiety |
1.8% |
Pain |
1.5% |
Intentional Overdose |
1.4% |
Constipation |
1.0% |
Autonomic Nervous System Imbalance |
0.9% |
Major Depression |
0.6% |
Cerebral Infarction |
0.6% |
Sleep Disorder Therapy |
0.6% |
Bipolar Disorder |
0.5% |
Headache |
0.4% |
Nasopharyngeal Cancer |
0.4% |
Coronary Artery Disease |
0.4% |
Mood Swings |
0.4% |
|
Somnambulism |
11.7% |
Product Substitution Issue |
11.6% |
Drug Ineffective |
11.3% |
Toxicity To Various Agents |
8.1% |
Respiratory Arrest |
6.1% |
Therapeutic Response Unexpected With Drug Substitution |
6.0% |
Delirium |
4.4% |
Amnesia |
4.2% |
Product Quality Issue |
4.2% |
Completed Suicide |
3.8% |
Road Traffic Accident |
3.5% |
Somnolence |
3.5% |
Intentional Drug Misuse |
3.4% |
Overdose |
3.0% |
Vomiting |
2.9% |
Fall |
2.7% |
Insomnia |
2.7% |
Poisoning |
2.6% |
Loss Of Consciousness |
2.5% |
Suicide Attempt |
2.1% |
|
Secondary |
Product Used For Unknown Indication |
43.6% |
Drug Use For Unknown Indication |
21.9% |
Insomnia |
7.9% |
Depression |
4.7% |
Drug Abuse |
3.6% |
Suicide Attempt |
3.1% |
Hypertension |
2.1% |
Pain |
2.1% |
Sleep Disorder |
1.7% |
Anxiety |
1.7% |
Prophylaxis |
1.2% |
Bipolar I Disorder |
1.0% |
Intentional Overdose |
1.0% |
Schizophrenia |
0.9% |
Bipolar Disorder |
0.8% |
Trigeminal Neuralgia |
0.7% |
Ill-defined Disorder |
0.7% |
Major Depression |
0.5% |
Back Pain |
0.5% |
Nausea |
0.5% |
|
Completed Suicide |
27.1% |
Respiratory Arrest |
12.3% |
Toxicity To Various Agents |
10.7% |
Poisoning |
6.2% |
Drug Toxicity |
4.9% |
Suicide Attempt |
4.8% |
Death |
4.3% |
Drug Abuse |
4.1% |
Cardio-respiratory Arrest |
3.5% |
Overdose |
3.3% |
Somnolence |
2.5% |
Cardiac Arrest |
2.3% |
Somnambulism |
2.2% |
Intentional Drug Misuse |
2.1% |
Vomiting |
2.1% |
Delirium |
1.8% |
Weight Increased |
1.6% |
Intentional Overdose |
1.4% |
Unresponsive To Stimuli |
1.4% |
Suicidal Ideation |
1.3% |
|
Concomitant |
Product Used For Unknown Indication |
30.8% |
Drug Use For Unknown Indication |
15.1% |
Insomnia |
7.9% |
Hypertension |
6.1% |
Pain |
5.2% |
Prophylaxis |
5.1% |
Depression |
4.9% |
Rheumatoid Arthritis |
3.3% |
Hepatitis C |
2.7% |
Sleep Disorder |
2.7% |
Anxiety |
2.5% |
Nausea |
2.0% |
Constipation |
1.9% |
Gastrooesophageal Reflux Disease |
1.7% |
Multiple Myeloma |
1.7% |
Diabetes Mellitus |
1.5% |
Asthma |
1.3% |
Atrial Fibrillation |
1.3% |
Breast Cancer |
1.2% |
Crohn's Disease |
1.2% |
|
Vomiting |
14.2% |
Weight Decreased |
7.4% |
Pneumonia |
6.8% |
Weight Increased |
6.2% |
Renal Failure Acute |
6.0% |
Death |
5.8% |
Nausea |
4.6% |
Pyrexia |
4.6% |
Pain |
4.5% |
Drug Ineffective |
4.4% |
Pulmonary Embolism |
4.2% |
Thrombocytopenia |
4.2% |
Urinary Tract Infection |
4.2% |
Tremor |
4.0% |
White Blood Cell Count Decreased |
3.6% |
Syncope |
3.2% |
Rash |
3.1% |
Completed Suicide |
3.0% |
Hyponatraemia |
3.0% |
Renal Failure |
3.0% |
|
Interacting |
Product Used For Unknown Indication |
25.4% |
Mental Disorder |
22.4% |
Major Depression |
10.7% |
Insomnia |
9.6% |
Drug Use For Unknown Indication |
6.1% |
Anxiety |
3.0% |
Depression |
3.0% |
Hypertension |
3.0% |
Pain |
3.0% |
Sleep Disorder |
2.3% |
Benign Prostatic Hyperplasia |
1.6% |
Dementia |
1.6% |
Blood Pressure Increased |
1.2% |
Myocardial Ischaemia |
1.2% |
Schizophrenia |
1.2% |
Back Pain |
0.9% |
Chronic Obstructive Pulmonary Disease |
0.9% |
Diabetes Mellitus |
0.9% |
Restlessness |
0.9% |
Sedation |
0.9% |
|
Drug Interaction |
24.3% |
Homicide |
17.6% |
Somnolence |
10.8% |
Respiratory Failure |
6.8% |
Suicidal Behaviour |
5.4% |
Insomnia |
4.1% |
Systemic Inflammatory Response Syndrome |
4.1% |
Traumatic Brain Injury |
4.1% |
Drug Withdrawal Syndrome |
2.7% |
Poor Quality Sleep |
2.7% |
Sedation |
2.7% |
Syncope |
2.7% |
Weight Decreased |
2.7% |
Blood Creatine Phosphokinase Increased |
1.4% |
Blood Pressure Decreased |
1.4% |
Blood Pressure Increased |
1.4% |
Condition Aggravated |
1.4% |
Confusional State |
1.4% |
Disorientation |
1.4% |
Drug Toxicity |
1.4% |
|